This brand name is authorized in Nigeria.
The drug AZUMA contains one active pharmaceutical ingredient (API):
1
|
UNII
5FD1131I7S - AZITHROMYCIN DIHYDRATE
|
|
Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-4450 | Tablet | Azuma-250 Tablets AZITHROMYCIN 250MG TAB 250 mg 1 X 6 | 104 RNW-PP-121341 Azuma-250 Tablets AZITHROMYCIN 250MG Azithromycin dihydrate 250mg, Sodium lauryl sulphate 13.5mg, Starch 15mg, Croscamellose Sodium 18mg, Colloidal anhydrous silica 4.5mg, Magnesium strearate 6.5mg, Tabcoate White 13.5mg B4-4450 Drugs Imported Products 16 Prescription Only Medicine (POM) 9/22/2020 ASPEN PHARMACARE NIGERIA LIMITED, plot 28,infinty house,ilupeju bypass 9062496814 dadeduro@ng.aspenpharma.com SHELYS PHARMACEUTICALS LTD, PLOT NO 696, NEW BAGAMOYO ROAD, MWENGE, P.O. BOX 32781, DAR ES SALAAM, TANZANIA, Tanzania | 30/11/2023 |
| B4-4451 | Tablet | Azuma 500 TAB 500 mg 1 X 3 | 105 RNW-PP-121338 Azuma 500 AZITHROMYCIN Azithromycin dihydrate 500mg, Calcium hydrogen phospahte 261, Sodium lauryi sulphate 27mg, Starch 30mg Croscamellose sodium 36mg, Colloidal anhydrous silica 9mg, Magnesium stearate 13mg, Tabcoat white 27mg B4-4451 Drugs Imported Products 13 Prescription Only Medicine (POM) 9/22/2020 ASPEN PHARMACARE NIGERIA LIMITED, plot 28,infinty house,ilupeju bypass 9062496814 dadeduro@ng.aspenpharma.com SHELYS PHARMACEUTICALS LTD, PLOT NO 696, NEW BAGAMOYO ROAD, MWENGE, P.O. BOX 32781, DAR ES SALAAM, TANZANIA, Tanzania | 30/11/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01FA10 | Azithromycin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-4450, B4-4451 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.